Medical Training AISchizophrenia Treatment and Antipsychotic Management
Select and manage antipsychotic therapy for schizophrenia, including clozapine initiation and long-acting injectable transitions, with confidence.
What this track covers
This track covers the clinical decision points in schizophrenia care: recognizing psychotic symptoms against DSM-5 criteria, choosing among first- and second-generation antipsychotics, and managing treatment-resistant cases with clozapine. It also addresses long-acting injectable selection and transition planning, alongside the role of psychosocial support in sustaining remission.
What you will practice
- Differentiate schizophrenia from other causes of psychosis using DSM-5 criteria
- Compare antipsychotic side-effect profiles when choosing an initial agent
- Identify criteria for treatment resistance that warrant a clozapine trial
- Plan a monitoring schedule for a patient starting clozapine
- Decide when and how to transition a patient to a long-acting injectable
Simulator scenario
A patient with persistent positive symptoms despite two adequate antipsychotic trials presents for evaluation of next treatment steps, including a discussion of clozapine.
Board question topics
- DSM-5 criteria for schizophrenia and differential diagnosis of psychosis
- Antipsychotic selection and side-effect management
- Clozapine monitoring requirements
- Long-acting injectable candidacy and transition planning
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free